Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Nihon Kyobu Shikkan Gakkai Zasshi|August 1, 1991
[A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer]H Ueoka, T Ohnoshi, T Moritaka, et al.
Acta Medica Okayama|February 1, 1992
Clinical features of 125 patients with sarcoidosis: Okayama University Hospital review of a recent 10-year periodS Hosoya, M Kataoka, Y Nakata, et al.
Internal Medicine (Tokyo, Japan)|March 1, 1993
Long-term results of combination chemotherapy with or without irradiation in small cell lung cancer: a 5- to 11-year follow-upT Ohnoshi, S Hiraki, N Ueda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1993
[Assessment of antitumor activity rhizoxin for human lung cancer cell lines: a potent new drug for drug-resistant lung cancer]N Takigawa, T Ohnoshi, H Ueoka, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1993
[A case of small cell lung cancer associated with diabetes insipidus and Cushing's syndrome]M Tabata, T Ohnoshi, H Ueoka, et al.
British Journal of Cancer|November 13, 2003
Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancerM Kawaraya, K Gemba, H Ueoka, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|September 1, 1992
[Six cases of primary pulmonary cryptococcosis]K Nishii, T Kodani, H Uji, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1989
[Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)]H Ueoka, T Ohnoshi, S Hiraki, et al.
Acta Medica Okayama|October 1, 1991
Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancerT Ohnoshi, S Hiraki, N Ueda, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|December 1, 1993
[CAV-PVP chemotherapy and sequential thoracic irradiation (TI) for patients with limited (LD) small cell lung cancer (SCLC)]H Ueoka, T Ohnoshi, S Hiraki, et al.
Pageof 11